12:00 - 13:00 ET
Webcast

Personalized Immunotherapy in Blood Cancer Treatment

Navigating blood cancer treatment often comes with questions and uncertainty. Join us for an empowering 1-hour session with Dr. Michael Chu, Clinician Scientist at the Cross Cancer Institute, to learn more about the benefits of personalized immunotherapy and how the immune system can act as a powerful tool in the treatment of blood cancers.  

 Learning Objectives: 

  • Greater understanding of personalized testing in cancer care  
  • Expanded knowledge on the latest treatment innovations and their efficacy  

  • Live Q&A: Take advantage of a 15-minute open forum to get reliable answers related to the webcast, directly from Dr. Chu.  
     

Who Should Attend:

  • Patients & Caregivers 
  • Healthcare & Psychosocial Staff 

Head shot of Dr. Michael Chu
Dr. Michael Chu

Dr. Michael Chu is a clinician scientist at the Cross Cancer Institute. He completed his medical training including General Internal Medicine residency and Medical Oncology fellowship at the University of Alberta. Dr. Chu was then awarded a Leukemia and Lymphoma Society fellowship for a combined clinical and research fellowship at Stanford University. Upon returning to Edmonton, his clinical focus includes lymphoma, myeloma, and central nervous system malignancies. Academically, his research focuses on basic and translational cancer research with an emphasis on immune therapy. He’s also participating in a wide range of clinical research.